학술논문

The MOTION study: a randomized, phase III study of vimseltinib for the treatment of tenosynovial giant cell tumor
Document Type
Review
Source
In: Future Oncology. (Future Oncology, 2023, 20(10):593-601)
Subject
Language
English
ISSN
17448301
14796694